Pharma Journalist - Page 794 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Sunesis Pharmaceuticals Announces Withdrawal of European MAA for Vosaroxin as a Treatment for Relapsed/Refractory AML

NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer’s Disease

GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD

Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications

Agreement to buy F-Star Alpha between Bristol-Myers Squibb and F-star Alpha terminated

Sorrento Therapeutics successfully completes acquisition of Virttu Biologics

Dr. Wilson appointed TAPIMMUNE President after Dr. Bonfiglio’s resignation

FDA approves Rydapt in combination with Chemotherapy for treatment of AML

MedMira receives CE Marks on its syphilis/HIV rapid test

Allergan completes acquisition of ZELTIQ Aesthetic